Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders.

Petrikis P, Tigas S, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V.

Int J Psychiatry Clin Pract. 2016 Sep;20(3):165-9. doi: 10.1080/13651501.2016.1197274. Epub 2016 Jun 23.

PMID:
27334805
2.

Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.

Garcia-Rizo C, Fernandez-Egea E, Oliveira C, Justicia A, Parellada E, Bernardo M, Kirkpatrick B.

Schizophr Res. 2012 Jan;134(1):16-9. doi: 10.1016/j.schres.2011.07.025. Epub 2011 Aug 9.

3.

Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.

Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, Josiassen RC.

J Clin Psychiatry. 2004 Nov;65(11):1491-8.

PMID:
15554761
4.

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis.

Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW; EUFEST Study Group.

Psychol Med. 2013 Dec;43(12):2571-82. doi: 10.1017/S0033291713000226. Epub 2013 Apr 17.

PMID:
23590895
5.

Risperidone added to clozapine: impact on serum prolactin levels.

Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D.

J Clin Psychiatry. 2001 Aug;62(8):605-8.

PMID:
11561931
6.

Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis.

González-Blanco L, Greenhalgh AMD, Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Kirkpatrick B.

Schizophr Res. 2016 Jul;174(1-3):156-160. doi: 10.1016/j.schres.2016.03.018. Epub 2016 Apr 6. Review.

PMID:
27068570
7.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA.

Schizophr Res. 2009 Feb;107(2-3):218-22. doi: 10.1016/j.schres.2008.09.019. Epub 2008 Nov 26.

PMID:
19038534
8.

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.

Kinon BJ, Gilmore JA, Liu H, Halbreich UM.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:55-68.

PMID:
12650681
9.

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.

Cookson J, Hodgson R, Wildgust HJ.

J Psychopharmacol. 2012 May;26(5 Suppl):42-51. doi: 10.1177/0269881112442016. Epub 2012 Apr 2. Review.

PMID:
22472310
10.

Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.

Montalvo I, Gutiérrez-Zotes A, Creus M, Monseny R, Ortega L, Franch J, Lawrie SM, Reynolds RM, Vilella E, Labad J.

PLoS One. 2014 Feb 24;9(2):e89428. doi: 10.1371/journal.pone.0089428. eCollection 2014.

11.

Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.

Lally J, Ajnakina O, Stubbs B, Williams HR, Colizzi M, Carra E, Fraietta S, Gardner-Sood P, Greenwood KE, Atakan Z, Mondelli V, Ismail K, Howes O, Taylor DM, Smith S, Hopkins D, Murray RM, Gaughran F.

Schizophr Res. 2017 Nov;189:117-125. doi: 10.1016/j.schres.2017.07.037. Epub 2017 Jul 27.

PMID:
28755878
12.

Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia.

Song X, Fan X, Zhang J, Zheng H, Li X, Pang L, Chen X, Zhang W, Harrington A, Ziedonis D, Lv L.

World J Biol Psychiatry. 2014 Sep;15(7):546-52. doi: 10.3109/15622975.2014.922699. Epub 2014 Jun 24.

PMID:
24959913
13.

Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.

Tsigkaropoulou E, Peppa M, Zompola C, Rizos E, Xelioti I, Chatziioannou S, Filippopoulou A, Lykouras L.

Gend Med. 2012 Feb;9(1):56-60. doi: 10.1016/j.genm.2012.01.001.

PMID:
22333523
14.

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.

Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS.

Schizophr Res. 2010 Jun;119(1-3):47-51. doi: 10.1016/j.schres.2009.12.035. Epub 2010 Jan 21.

15.

Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.

Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A.

Int Clin Psychopharmacol. 2007 Jul;22(4):192-6.

PMID:
17519641
16.

Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naïve patients with psychosis.

Petrikis P, Boumba VA, Tzallas AT, Voulgari PV, Archimandriti DT, Skapinakis P, Mavreas V.

Psychiatry Res. 2016 Dec 30;246:348-352. doi: 10.1016/j.psychres.2016.09.053. Epub 2016 Sep 28.

PMID:
27764741
17.

Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.

Albayrak Y, Beyazyüz M, Beyazyüz E, Kuloğlu M.

Nord J Psychiatry. 2014 Jul;68(5):341-6. doi: 10.3109/08039488.2013.839739. Epub 2013 Oct 7.

PMID:
24094029
18.

Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.

Lawford BR, Barnes M, Connor JP, Heslop K, Nyst P, Young RM.

J Psychopharmacol. 2012 Feb;26(2):324-9. doi: 10.1177/0269881110393051. Epub 2011 Jan 24.

PMID:
21262859
19.

Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis.

Huber TJ, Borsutzky M, Schneider U, Emrich HM.

Acta Psychiatr Scand. 2004 Apr;109(4):269-74.

PMID:
15008800
20.

Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.

Ittig S, Studerus E, Heitz U, Menghini-Müller S, Beck K, Egloff L, Leanza L, Andreou C, Riecher-Rössler A.

Schizophr Res. 2017 Nov;189:111-116. doi: 10.1016/j.schres.2017.02.010. Epub 2017 Feb 14.

PMID:
28214176

Supplemental Content

Support Center